If you have been reading about lyophilized powder and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2025-08-24. Where a claim depends on a specific study, the study is described rather than over-claimed.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
AOD-9604 is prohibited in sport by the World Anti-Doping Agency under the peptide hormone class. Its presence in a sample can be detected through mass spectrometry-based methods, although the exact assay depends on the laboratory. In research settings, material is often supplied as a lyophilized powder for reconstitution. Buyers and researchers should note that products labeled AOD-9604 may vary in purity and actual peptide content. Analytical certificates and independent testing are common ways to verify identity, but no global harmonized standard exists for all commercial lots.
AOD-9604 is a synthetic peptide whose sequence is modeled on the C-terminal region of human growth hormone. Published descriptions commonly place it as a modified fragment corresponding to hGH amino acids 176–191, with a tyrosine residue added or retained at the N-terminus to support detection and handling. It is not intact growth hormone and lacks the full receptor-binding architecture of the parent protein. The molecule was developed as a research candidate for metabolic studies rather than as a replacement for growth hormone therapy. Its identity is defined by its amino acid sequence rather than by any single commercial preparation.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20°C or below | Protect from light and moisture |
| Analytical method | RP-HPLC | Purity and identity assessment |
| Mass confirmation | Mass spectrometry | Verifies molecular mass |
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD-9604 is a synthetic peptide that corresponds to a short section of human growth hormone. It is commonly identified as hGH fragment 176-191 because its sequence matches residues at the C-terminal end of the hormone. The molecule contains sixteen amino acids and is made by solid-phase peptide synthesis. Researchers study it for metabolic effects rather than for the growth-promoting actions associated with full human growth hormone. Its small size distinguishes it from the complete 191-amino-acid hormone.
Several names appear in scientific and commercial settings. AOD9604 and AOD-9604 are development codes used interchangeably, while hGH fragment 176-191 describes the same region. The peptide includes a disulfide bond between two cysteine residues, which helps shape its three-dimensional structure. Different suppliers may provide acetate or other salt forms, and purity can vary. These differences matter because analytical tests and biological assays can respond to the specific form being studied.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
The film was completed for around $20 million. A North American B-25J Mitchell known as "Photo Fanny" (from the Planes of Fame Museum in Chino, California) is featured prominently in the film, both as the B-25 prototype and later as the restored warbird McCormick flies to his beloved
Absolute numbers vary between pets, and with meter calibrations. Glucometers made for humans are generally accurate using feline blood except when reading lower ranges of blood glucose (<80 mg/dl–4.44 mmol/L). At this point the size difference in human and animal red blood cells can create inaccurate readings.
Populations susceptible to copper deficiency include those with genetic defects for Menkes disease, low-birth-weight infants, infants fed cow's milk instead of breast milk or fortified formula, pregnant and lactating mothers, patients receiving total parenteral nutrition, individuals with "malabsorption syndrome" (impaired dietary absorption), diabetics, individuals with chronic diseases that result in low food intake, such as alcoholics, and persons with eating disorders. The elderly and athletes may also be at higher risk for copper deficiency due to special needs that increase the daily requirements. Vegetarians may have decreased copper intake due to the consumption of plant foods in which copper bioavailability is low. On the other hand, Bo Lönnerdal commented that Gibson's study showed that vegetarian diets provided larger quantities of copper. Fetuses and infants of severely copper deficient women have increased risk of low birth weights, muscle weaknesses, and neurological problems. Copper deficiencies in these populations may result in anemia, bone abnormalities, impaired growth, weight gain, frequent infections (colds, flu, pneumonia), poor motor coordination, and low energy.
Little Caesars produces a variety of pizzas. Several core menu items are part of the HOT-N-READY menu, designed to make popular items available for immediate carry-out, while others are considered either specialty pizzas or custom pizzas. In 2013, they added the Deep! Deep! Dish Pizza, a Detroit-style pizza, to the menu. Additional entrée options include flavored Caesar Wings and bread, such as Crazy Bread and Italian Cheese Bread. Select locations offer salads. All Little Caesars locations carry Pepsi products. Little Caesars also sells brownies. In 1996, they introduced Pizza by the Foot, a three-foot-long rectangular pizza. The product has since been discontinued; however, its equivalent, Pizza by the Meter, has been sold in the Saudi Arabian market since the 90s and is a top-rated product. On occasion, Little Caesars releases limited time offers. In 2014, they introduced the Soft Pretzel Crust Pizza, and in 2015, the "Bacon Wrapped Deep! Deep! Dish Pizza." In May 2019, Little Caesars began testing a pizza with meatless sausage made by Impossible Foods. In June 2020, Little Caesars reintroduced Stuffed Crazy Bread. They first introduced it in 1995. The original Crazy Bread was first introduced in 1982. As of May 15, 2023, Little Caesars introduced Crazy Puffs in Canada as a handheld snack made with pizza dough filled with cheese, pepperoni, and sauce, topped with garlic sauce and herbs. They later launched in the U.S. on March 11, 2024, offering both pepperoni and cheese varieties.
=== Regulation of plant growth === In plants, signaling by auxins, or phytohormones that order the direction and tropism of plant growth, induces the targeting of a class of transcription factor repressors known as Aux/IAA proteins for proteasomal degradation. These proteins are ubiquitinated by SCFTIR1, or SCF in complex with the auxin receptor TIR1. Degradation of Aux/IAA proteins derepresses transcription factors in the auxin-response factor (ARF) family and induces ARF-directed gene expression. The cellular consequences of ARF activation depend on the plant type and developmental stage, but are involved in directing growth in roots and leaf veins. The specific response to ARF derepression is thought to be mediated by specificity in the pairing of individual ARF and Aux/IAA proteins.
Sources: en.wikipedia.org
Dorothy Hodgkin on Nobelprize.org including the Nobel Lecture, 11 December 1964 The X-ray Analysis of Complicated Molecules Portraits of Dorothy Hodgkin at the National Portrait Gallery, London Works by or about Dorothy Hodgkin at the Internet Archive Four interviews with Dorothy Crowfoot Hodgkin recorded between 1987 and 1989 in partnership with the Royal College of Physicians are held in the Medical Sciences Video Archive in the Special Collections at Oxford Brookes University: Professor Dorothy Crowfoot Hodgkin OM FRS in interview with Sir Gordon Wolstenholme: Interview 1 (1987). Professor Dorothy Crowfoot Hodgkin OM FRS in interview with Max Blythe: Interview 2 (1988). Professor Dorothy Crowfoot Hodgkin OM FRS in interview with Max Blythe: Interview 3 (1989). Professor Dorothy Crowfoot Hodgkin OM FRS at home talking with Max Blythe: Interview 4 (1989). Watch a lecture of Dorothy Crowfoot Hodgkin (1910–1994) at the 1988 Nobel Laureates Symposium at the annual meeting of the American Crystallographic Association, Philadelphia Dorothy Hodgkin featured on the BBC Radio 4 program In Our Time on 3 October 2019. "The exceptional life of Dorothy Crowfoot Hodgkin", BBC "Ideas" video, 27 September 2021
1st Airborne Battle Group (ABG), 187th Infantry (reassigned from the 24th Infantry Division on 8 February 1959)(1) 1st ABG, 325th Infantry 2nd ABG, 501st Infantry 1st ABG, 503d Infantry (reassigned from the 24th Infantry Division on 1 July 1958)(2) 2nd ABG, 503rd Infantry (reassigned to the 25th Infantry Division on 24 June 1960) 1st ABG, 504th Infantry (reassigned to the 8th Infantry Division on 11 December 1958) 2nd ABG, 504th Infantry (assigned effective 9 May 1960)(1) 1st ABG, 505th Infantry (reassigned to the 8th Infantry Division on 15 January 1959) (1) 1st ABG, 504th Infantry and 1st ABG, 505th Infantry were reassigned to the 8th Infantry Division in central West Germany to provide airborne capability in Germany; in turn, 1–187th and 1-503d were reassigned from the 24th Infantry Division in southern Germany to the 82nd Airborne Division (2) 2nd ABG, 503rd Infantry was reassigned to the 25th Infantry Division and stationed in Okinawa to provide airborne capability in the Pacific on 24 June 1960. This ABG was reassigned to the 173d Airborne Brigade on 26 March 1963.
=== Shang dynasty === Traces of therapeutic activities in China date from the Shang dynasty (14th–11th centuries BCE). Though the Shang did not have a concept of "medicine" as distinct from other health practices, their oracular inscriptions on bones and tortoise shells refer to illnesses that affected the Shang royal family: eye disorders, toothaches, bloated abdomen, and such. Shang elites usually attributed them to curses sent by their ancestors. There is currently no evidence that the Shang nobility used herbal remedies. Stone and bone needles found in ancient tombs led Joseph Needham to speculate that acupuncture might have been carried out in the Shang dynasty. This being said, most historians now make a distinction between medical lancing (or bloodletting) and acupuncture in the narrower sense of using metal needles to attempt to treat illnesses by stimulating points along circulation channels ("meridians") in accordance with beliefs related to the circulation of "Qi". The earliest evidence for acupuncture in this sense dates to the second or first century BCE.
A Type I civilization (planetary) is able to access all the energy available on its planet and store it for consumption. A Type II civilization (stellar) can directly consume a star's energy, such as through the use of a Dyson sphere. A Type III civilization (galactic) is able to capture all the energy emitted by its galaxy, and every object within it, such as every star, black hole, etc. Under this scale, the sum of human civilization does not yet reach Type I status, though it approaches it. Extensions of the scale have since been proposed, including a wider range of power levels (Types 0, IV, and V) and the use of metrics other than pure power, e.g., computational growth or food consumption.
Sources: en.wikipedia.org
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.
Lyophilized powder should be stored at -20°C or lower, protected from light and moisture. Reconstituted solutions are less stable and should be aliquoted to avoid freeze-thaw cycles. Always follow supplier instructions.
Variability in purity, counterion content, and residual solvents is possible. Independent testing and certificates of analysis help verify quality. Microbial contamination can occur if handling is not sterile.
No. It is a synthetic peptide fragment modeled on part of human growth hormone, not the full hormone. It does not contain the complete sequence or receptor-binding regions of hGH.